Asepha
Overview
Asepha is a Toronto-based startup focused on leveraging artificial intelligence to streamline operations in the pharmacy sector. Established in 2023 by Eunice Wu and Can Uncu, the company has been instrumental in providing AI-driven solutions that automate administrative workflows, allowing pharmacists more time for clinical duties. Asepha has garnered financial support amounting to $4 million from investors such as Glasswing Ventures and Core Innovation Capital. The company is headquartered in Toronto, Canada, and is making significant strides in expanding its market presence.
Recent Developments
In the past couple of years, Asepha has made several notable advancements:
- July 2025: The company secured $4 million in a seed funding round led by Glasswing Ventures and Core Innovation Capital, with additional investments from Panache, RedBud, MGV, Ripple Ventures, and Front Row Ventures. This funding will aid in doubling the staff and facilitating the opening of a new office in New York City.
- Early 2025: Asepha focused on scaling its engineering and go-to-market teams, enhancing its AI product capabilities, and forming deeper partnerships with leading pharmaceutical organizations.
- Late 2024: Asepha participated in Google for Startups Cloud AI Accelerator, illustrating its commitment to tackling complex challenges in deploying scalable, high-trust AI.
- June 2024: The company was awarded the top prize at the Provider Care Coordination Competition hosted by Tampa General Hospital, reflecting its innovative prowess in the pharmacy tech landscape.
- April 2024: Engaged in pilot programs with major pharmaceutical chains across North America, enhancing its interoperability and reliability through real-time web-based tasks and AI-driven administrative—functions.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2023 |
| Headquarters | Toronto, Ontario, Canada |
| Founders | Eunice Wu, Can Uncu |
| Revenue | <$5 Million |
| Profits | Not disclosed |
| Key Investors | Glasswing Ventures, Core Innovation Capital, Panache, RedBud, MGV, Ripple Ventures, Front Row Ventures |
| Industry | Hospitals and Health Care |
| Number of Employees | Approximately 25 |
Early History
Asepha emerged from the vision of Eunice Wu, who utilized her considerable experience as a pharmacist. Wu was continually frustrated by the amount of administrative work detracting from patient care and sought a solution that would optimize pharmacy operations. Partnering with Can Uncu, an AI technology expert from AMD, they founded Asepha in 2023. The startup received initial funding of $200,000 USD, allowing them to develop a suite of AI solutions that address data entry inefficiencies, prescription processing, and customer interactions, specifically tailored for the pharmaceutical industry.
Company Profile and Achievements
Asepha’s business model focuses on empowering pharmacists to streamline tasks traditionally requiring substantial human intervention. Key achievements include:
- AI Solutions: Development of an OCR prescription entry agent achieving 96% accuracy, significantly reducing manual data entry effort.
- Workflow Automation: Implementation of a call agent automating 70% of inbound phone calls and a browser navigation agent to handle real-time web tasks, leading to enhanced operational efficiency.
- Integration Capabilities: Successfully integrating their AI tools with existing pharmacy computer systems using a simple API to overcome regulations in adopting new tech.
- Market Impact: Reporting a 32% reduction in manual labor costs and pharmacists completing administrative tasks four times faster since integrating Asepha's solutions.
Current Operations and Market Position
Currently, Asepha is expanding its operations domestically and internationally. The recent funding round has positioned the company to bolster its U.S. presence, with a new office in New York. Asepha prides itself on its interoperable AI agents that cater to large-scale pharmacies, including several Fortune 50 customers, reinforcing its significant footprint in the North American pharmacy tech market. The company's competitive edge lies in its deep industry knowledge combined with advanced AI technologies, enabling more personalized and efficient pharmacy services.
Asepha Funding
Asepha's funding strategy has been pivotal in its quick scaling and technological development:
- Led by venture firms such as Glasswing Ventures and Core Innovation Capital.
- Generated over $4.02 million through strategic rounds to drive engineering and market expansion, signaling investor confidence in its market potential and technology.
Asepha Careers
Asepha’s growth opens up numerous career opportunities across various domains including AI engineering, market development, and customer relations. It aims to double its workforce following the latest funding and build a robust team to support its expanding operations.
Conclusion
Asepha stands as a transformative force in pharmacy operations, utilizing AI to bridge the gap between administrative tasks and patient care. Its innovative solutions continue to propel the company toward a significant impact in the healthcare sector, especially amidst rising demand for intelligent systems in pharmaceutical management. Looking ahead, Asepha is poised for expansion into new geographical regions, leveraging its strong foundational technology to address global pharmacy challenges.